Paper36917951
B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity.
Laumont CM and 1 other. Cancer Cell, 2023. Cited by 228 papers, by iCite.
Cite this record
ConductScience Library. B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity. Papers, record 36917951. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36917951
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Humans | |
| B-Lymphocytes | |
| Lymphocytes, Tumor-Infiltrating | |
| T-Lymphocytes | |
| Prognosis | |
| Tumor Microenvironment |
Source PubMed
Cited by180
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 228 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42920923 | Senescence and tumor immunology: A multifaceted interplay of influence. | iScience | 2026 | https://conductscience.org/library/papers/42920923 | PubMed |
| 42872124 | Integrated Multi-Time-Point 18F-FAPI PET/CT and Immune Histopathology for Predicting Pathological Complete Response in Microsatellite-Stable Locally Advanced Rectal Cancer Treated With Neoadjuvant Radiotherapy, Chemotherapy, and Immunotherapy. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42872124 | PubMed |
| 42846924 | The multifaceted roles of tumor-infiltrating plasma cells in cancer immunology. | Fundam Res | 2026 | https://conductscience.org/library/papers/42846924 | PubMed |
| 42845511 | Tissue-resident memory B cells augment local anti-cancer immunity via IgA. | bioRxiv | 2026 | https://conductscience.org/library/papers/42845511 | PubMed |
| 42830947 | Immune-Cell Dynamics in the Tumor Microenvironment: Implications for Cancer Therapy. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42830947 | PubMed |
| 42776800 | B Cells and Tumor Immunometabolism: Emerging Insights into Immune Regulation and Therapeutic Resistance. | Antibodies (Basel) | 2026 | https://conductscience.org/library/papers/42776800 | PubMed |
| 42741133 | Prognostic significance of the MELK/TMPO-AS1/hsa-let-7b-5p network in lung adenocarcinoma. | Front Oncol | 2026 | https://conductscience.org/library/papers/42741133 | PubMed |
| 42723305 | BRCA1/2-stratified immune profiling of treatment-naive high-grade serous ovarian cancer ascites identifies a Treg-enriched ascitic immune phenotype. | J Pathol Transl Med | 2026 | https://conductscience.org/library/papers/42723305 | PubMed |
| 42683405 | CD86-Positive Mature Tertiary Lymphoid Structures Are Associated With CD8+ T-Cell Infiltration and Favorable Clinical Outcomes in Pancreatic Ductal Adenocarcinoma. | Ann Gastroenterol Surg | 2026 | https://conductscience.org/library/papers/42683405 | PubMed |
| 42674818 | Multi-omics Investigations of Immune Microenvironment of Human Colorectal Cancer. | Cancer Genomics Proteomics | 2026 | https://conductscience.org/library/papers/42674818 | PubMed |
| 42613326 | Humoral immunity in cancer. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42613326 | PubMed |
| 42597660 | B cell receptor-based hybridoma enrichment enables discovery of antibodies against intracellular tumor antigens. | Front Immunol | 2026 | https://conductscience.org/library/papers/42597660 | PubMed |
| 42588726 | Immunological and Clinical Outcomes Associated with Histotripsy Ablation in Spontaneously Occurring Canine Osteosarcoma; Veterinary Clinical Trial Results. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42588726 | PubMed |
| 42571170 | High-titer antinuclear antibodies are associated with severe immune-related toxicity and exploratory survival outcomes in advanced gastric cancer immunotherapy. | Ther Adv Med Oncol | 2026 | https://conductscience.org/library/papers/42571170 | PubMed |
| 42516376 | Effective analysis of testicular seminoma toxicity and mechanisms of acetyl tributyl citrate using network toxicology, bulk RNA sequencing data, single-cell RNA sequencing data, and clinical data. | Front Immunol | 2026 | https://conductscience.org/library/papers/42516376 | PubMed |
| 42508408 | Tumor-infiltrating plasma cell profiling after PD-1 blockade reveals tumor-specific antibodies. | Cancer Cell | 2026 | https://conductscience.org/library/papers/42508408 | PubMed |
| 42491333 | A bioinformatics analysis of KIF transcriptomic subtyping reveals prognostic heterogeneity and differential therapeutic responses in cervical cancer. | Oncol Lett | 2026 | https://conductscience.org/library/papers/42491333 | PubMed |
| 42487238 | Identification of an Immune Cell Gene Signature for Predicting Response and Prognosis in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy. | Cancer Med | 2026 | https://conductscience.org/library/papers/42487238 | PubMed |
| 42445408 | A Breg-associated lncRNA signature predicts prognosis and immune landscape in esophageal carcinoma. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42445408 | PubMed |
| 42445385 | Single-cell mitophagy patterns dictate intercellular crosstalk in the tumor microenvironment to promote osteosarcoma progression. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42445385 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36917951
GET https://conductscience.org/api/papers/v1/36917951/cited_by?page=2